| Literature DB >> 25055721 |
Tai-Hua Yang, Hsin-Chen Chen, Yung-Chun Liu, Hui-Hsuan Shih, Li-Chieh Kuo, Stephen Cha, Hsiao-Bai Yang, Dee-Shan Yang, I-Ming Jou, Yung-Nien Sun1, Fong-Chin Su.
Abstract
BACKGROUND: The treatment of trigger finger so far has heavily relied on clinicians' evaluations for the severity of patients' symptoms and the functionality of affected fingers. However, there is still a lack of pathological evidence supporting the criteria of clinical evaluations. This study's aim was to correlate clinical classification and pathological changes for trigger finger based on the tissue abnormality observed from microscopic images.Entities:
Mesh:
Year: 2014 PMID: 25055721 PMCID: PMC4118632 DOI: 10.1186/1475-925X-13-100
Source DB: PubMed Journal: Biomed Eng Online ISSN: 1475-925X Impact factor: 2.819
Figure 1Features of A1 pulley in normal and trigger finger. (A) Normal A1 pulley tissue with pink collagen deposits and fibrocytes with elongated nuclei; (B) Trigger finger A1 pulley tissue, presence of chondroid metaplasia with a blue-color chondromyxoid matrix and rounded nuclei of chondrocytes.
Figure 2Color normalization. Original image (A) and (C); Normalized results (B) and (D), respectively.
Figure 3Results in different steps of processing. (A) The normalized images of the three pathological grades. (B) The color segmentation (white: abnormal tissue region, black: normal tissue region, blue: empty background). (C) The nuclei classification (red: normal, green: abnormal).
Mean Abn-SR and Abn-NR in pathological grades and in Froimson’s clinical severity classification respectively
| | ||||||
|---|---|---|---|---|---|---|
| 0.14 ± 0.03 | 0.20 ± 0.01 | 0.26 ± 0.01 | 0.16 ± 0.05 | 0.20 ± 0.03 | 0.26 ± 0.01 | |
| 0.57 ± 0.07 | 0.64 ± 0.04 | 0.74 ± 0.05 | 0.59 ± 0.07 | 0.65 ± 0.04 | 0.74 ± 0.06 | |
Abbreviations: Abn-SR ratio of abnormal region, Abn-NR ratio of abnormal nuclei.
Figure 4Analysis of two parameters in pathological grades. (A) Ratio of abnormal region (Abn-SR, p < 0.0001). (B) Ratio of abnormal nuclei (Abn-NR, p < 0.0001).
Figure 5Analysis of two parameters in Froimson’s clinical severity classification. (A) Ratio of abnormal region (Abn-SR, p = 0.0003). (B) Ratio of abnormal nuclei (Abn-NR, p = 0.0005).
-value of Post hoc pairwise comparisons under LSD rule between pathological grades and between clinical severity classifications respectively
| | ||||||
|---|---|---|---|---|---|---|
| <0.0001* | <0.0001* | <0.0001* | <0.0001* | 0.0104* | 0.0602 | |
| <0.0001* | 0.0242* | 0.0022* | <0.0001* | 0.0123* | 0.0931 | |
Abbreviations: Abn-SR ratio of abnormal region, Abn-NR ratio of abnormal nuclei; *, significant difference.
Distribution and contingency analysis of clinical severity classification according to pathological grades (Cohen’s kappa coefficient = 0.717)
| | |||||
|---|---|---|---|---|---|
| L grade | 5 (100%) | 0 | 0 | 5 | |
| M grade | 3 (37.5%) | 5 (62.5%) | 0 | 8 | |
| H grade | 0 | 1 (12.5%) | 7 (87.5%) | 8 | |
| Total | 8 (38.1%) | 6 (28.6%) | 7 (33.3%) | 21 | |